Top

Published in:

01-12-2020 | Laser | Review Article

Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis

Authors: Thalita Molinos Campos, Carolina Antunes do Prado Tavares Silva, Ana Paula Taboada Sobral, Sergio Sousa Sobral, Maria Fernanda Setúbal Destro Rodrigues, Sandra Kalil Bussadori, Kristianne Porta Santos Fernandes, Raquel Angnelli Mesquita-Ferrari, Anna Carolina Ratto Tempestini Horliana, Lara Jansiski Motta

Published in: Supportive Care in Cancer | Issue 12/2020

Abstract

Background

Oral mucositis (OM) is an oral toxicity caused by cancer treatment, found often in patients with head and neck cancer. Low-intensity laser therapy for OM has anti-inflammatory, analgesic, and tissue reparative properties.

Objective

The objective of this work is to perform a systematic review and meta-analysis of the randomized clinical trials of OM laser therapy in patients undergoing treatment for head and neck cancers, followed by a cost-effectiveness analysis of the therapy.

Method

The search terms, mucositis and phototherapy, laser therapy and mucositis, photobiomodulation and mucositis, and low-level laser therapy and mucositis, were used to search the databases of PubMed, Web of Science, and MEDLINE. Randomized clinical trials were divided into two groups: one treated with laser therapy and the other given a placebo. Only 13 studies were included in the systematic review, and 6 studies in the meta-analysis.

Results

The results of the systematic review and meta-analysis show that the laser therapy presented good results in clinical improvement and pain reduction, decreasing the patients’ likelihood of developing OM, with degrees of debilitating lesions, to 64% (RR = 0.36 [95% CI = 0.29–0.44]). The cost-effectiveness analysis revealed an incremental cost of R$ 3687.53 for the laser group, with an incremental effectiveness of 132.2. The incremental cost-effectiveness ratio (ICER) was 27.89, for the severe OM cases that were avoided.

Conclusion

It was concluded, therefore, that photobiomodulation for OM in patients receiving head and neck cancer treatment was clinically effective and cost-effective.

Available only for authorised users

Bensadoun RJ, Nair RG (2012) Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: state of the art based on literature review and meta-analysis. Curr Opin Oncol 24(4):363–370. https://doi.org/10.1097/cco.0b013e328352eaa3CrossRefPubMed

Mañas A, Cerezo L, de la Torre A et al (2012) Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy. Clin Transl Oncol 14(10):740–746. https://doi.org/10.1007/s12094-012-0861-8CrossRefPubMed

Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya GA (2012) Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral câncer patients: a randomized controlled trial. Oral Oncol 48(9):893–897. https://doi.org/10.1016/j.oraloncology.2012.03.008CrossRefPubMed

Cruz LB, Ribeiro AS, Rech A, Rosa LGN, Castro CG Jr, Brunetto AL (2007) A influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 48:435–444. https://doi.org/10.1002/pbc.20943CrossRefPubMed

Lima AG, Villar RC, Castro GJ et al (2012) Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82(1):270–275. https://doi.org/10.1016/j.ijrobp.2010.10.012CrossRef

Jensen SB, Jarvis V, Zadik Y et al (2013) Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer 21(11):3223–3232. https://doi.org/10.1007/s00520-013-1884-6CrossRefPubMed

Saunders DP, Epstein JB, Elad S et al (2013) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21(11):3191–3207. https://doi.org/10.1007/s00520-014-2542-3CrossRefPubMed

Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N (2006) Lost in knowledge translation: time for a map? J Contin Educ Heal Prof 26(1):13–24. https://doi.org/10.1002/chp.47CrossRef

Hagiwara S, Iwasaka H, Okuda K, Noguchi T (2007) GaIAIs (830nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med 39(10):797–802. https://doi.org/10.1002/lsm.20583CrossRefPubMed

10.

Soárez PC (2014) Decision models for economic evaluations of health technologies. Rev Ciência Saúde Coletiva 19(10):4209–4222. https://doi.org/10.1590/1413-812320141910.02402013CrossRef

11.

Changik JO (2014) Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 20(4):327–337. https://doi.org/10.3350/cmh.2014.20.4.327CrossRef

12.

Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol BiolPhys 68(4):1110–1120. https://doi.org/10.1016/j.ijrobp.2007.01.053CrossRef

13.

World Health Organization (2003) Making choices in health: WHO guide to cost-effectiveness analysis. https://www.who.int/choice/book/en/. Accessed 10 June 2019

14.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E, ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force (2013) Consolidated health economic evaluation reporting standards (CHEERS) explanation and elaboration: a report of the ISPOR health economic evaluations publication guidelines good reporting practices task force. Value Health 16(2):231–250. https://doi.org/10.1016/j.jval.2013.02.002CrossRefPubMed

15.

Drummond MF, Sculpher MJ, Claxton K et al (2015) Methods for the economic evaluation of health care Programmes. Oxford University Press

16.

Brazil Ministry of Health (2012) Executive secretary. Economic Area of Health and Development

17.

Moraz G, Garcez AS, Assis EM et al (2015) Health cost-effectiveness studies in Brazil: a systematic review. Ciênc Saúde Coletiva 20(10):3211–3229. https://doi.org/10.1590/1413-812320152010.00962015CrossRef

18.

Antunes HS, Schluckebier LF, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, Rampini MP, Ferreira EMS, Dias FL, Teich V, Teich N, Ferreira CG (2016) Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncol 52:85–90. https://doi.org/10.1016/j.oraloncology.2015.10.022CrossRefPubMed

19.

Silva EM, Silva MT, Augustovski F et al (2017) Guidelines for reporting economic evaluation studies. Epidemiol Serv Saude 26(4):895–898. https://doi.org/10.5123/S1679-49742017000400020CrossRefPubMed

20.

Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S (2013) Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial. Support Care Cancer 21:1421–1428. https://doi.org/10.1007/s00520-012-1684-4CrossRefPubMed

21.

Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM (2012) Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients- a triple blinded randomized controlled trial. Radiother Oncol 104:349–354. https://doi.org/10.1016/j.radonc.2012.06.011CrossRefPubMed

22.

Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Guddattu V (2015) Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients- a randomized placebo-controlled trial. J Photochem Photobiol B Biol 144:51–56. https://doi.org/10.1016/j.jphotobiol.2015.01.011CrossRef

23.

Oton-Leite AF, Elias LSA, Morais OM et al (2013) Effect of low-level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dentist 33(6):294–300. https://doi.org/10.1111/j.1754-4505.2012.00303.xCrossRefPubMed

24.

Oton-Leite AF, Silva GBL, Morais OM et al (2015) Effect of low-level laser therapy on Chemoradiotherapy-induced Oral Mucositis and salivary inflammatory mediators in head and neck Cancer patients. Lasers Surg Med 47:296–305. https://doi.org/10.1002/lsm.22349CrossRefPubMed

25.

Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, Cabral E, Rampini MP, Rodrigues PC, Silva TGP, Ferreira EMS, Dias FL, Ferreira CG (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol 109(2):297–302. https://doi.org/10.1016/j.radonc.2013.08.010CrossRefPubMed

26.

Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, de Assis Ramos G, Dias FL, Ferreira CG (2017) Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis. Oral Oncol 71:11–15. https://doi.org/10.1016/j.oraloncology.2017.05.018CrossRefPubMed

27.

Arora H, Pai KM, Maiya A, Vidyasagar MS, Rajeev A (2008) Efficacy of he-ne laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(2):180–186. https://doi.org/10.1016/j.tripleo.2007.07.043CrossRefPubMed

28.

Carvalho PA, Jaguar GC, Pellizzon AC et al (2011) Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients. Oral Oncol 47(12):1176–1181. https://doi.org/10.1016/j.oraloncology.2011.08.021CrossRefPubMed

29.

Shaw MJ, Kumar NDK, Duggal M, Fiske J, Lewis DA, Kinsella T, Nisbet T (2000) Oral management of patients following oncology treatment: literature review. Br Assoc Oral Maxillofac Surg 38:519–524. https://doi.org/10.1054/bjom.2000.0468CrossRef

30.

Rosenthal DI, Trotti A (2009) Strategies for managing radiation. Induced Mucositis in Head and Neck Cancer. Semin Radiat Oncol 19:29–34. https://doi.org/10.1016/j.semradonc.2008.09.006CrossRefPubMed

31.

Singh N, Scully C, Joyston-bechal S (1996) Oral complications of Cancer therapies: prevention and management. Clin Oncol 8:15–24. https://doi.org/10.1016/S0936-6555(05)80034-2CrossRef

32.

Genot-Klastersky MT, Klastersky J, Awada F et al The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer 16(12):1381–1387. https://doi.org/10.1007/s00520-008-0439-8

33.

Simões A, Eduardo FP, Luiz AC, Campos L, Sá PHRN, Cristófaro M, Marques MM, Eduardo CP (2009) Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers. Lasers Surg Med 41(4):264–270. https://doi.org/10.1002/lsm.20758CrossRefPubMed

34.

Worthington HV, Clarkson JE, Eden OB (2006) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2. https://doi.org/10.1002/14651858.CD000978.pub2

35.

Silva GB, Sacono NT, Oton-Leite AF et al (2015) Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci 30(1):117–126. https://doi.org/10.1007/s10103-014-1624-2CrossRefPubMed

36.

Silva GB, Mendonça EF, Bariani C et al (2014) The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial. Photomed Laser Surg 29(1):27–31. https://doi.org/10.1089/pho.2009.2699CrossRef

37.

Figueiredo ALP, Lins L, Cattony AC, Falcão AFP (2013) Laser therapy in the control of oral mucositis: a meta-analysis. Ver Ass Med Bras 59:467–474. https://doi.org/10.1016/j.ramb.2013.08.003CrossRef

38.

Lima VHS, Oliveira-Neto OB, Sales PHH et al (2020) Effectiveness of low-level laser therapy for oral mucositis prevention in patients undergoing chemoradiotherapy for the treatment of head and neck cancer: a systematic review and meta-analysis. Oral Oncol 102:104524. https://doi.org/10.1016/j.oraloncology.2019.104524CrossRefPubMed

39.

Zadik Y, Arany PR, Fregnani ER et al (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27(10):3969–3983. https://doi.org/10.1007/s00520-019-04890-2CrossRefPubMed

40.

Bjordal JM, Bensadoun RJ, Tunèr J, Frigo L, Gjerde K, Lopes-Martins RAB (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer 19(8):1069–1077. https://doi.org/10.1007/s00520-011-1202-0CrossRefPubMed

41.

Peng H, Chen BB, Chen L, Chen YP, Liu X, Tang LL, Mao YP, Li WF, Zhang Y, Lin AH, Sun Y, Ma J (2017) A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy. Oral Oncol 75:89–94. https://doi.org/10.1016/j.oraloncology.2017.11.001CrossRefPubMed

42.

Bezinelli LM, Eduardo FP, Lopes RMG et al (2014) Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol 32:31–39. https://doi.org/10.1002/hon.2050CrossRefPubMed

43.

Zanin T, Zanin F, Carvalhosa AA, de Souza Castro PH, Pacheco MT, Zanin ICJ, Brugnera A Jr (2008) Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. Photomed Laser Surg 28(2):233–237. https://doi.org/10.1089/pho.2008.2242CrossRef

44.

Hodgson BD, Margolis DM, Salzman DE, Eastwood D, Tarima S, Williams LD, Sande JE, Vaughan WP, Whelan HT (2012) Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer 20(7):1405–1415. https://doi.org/10.1007/s00520-011-1223-8CrossRefPubMed

Title: Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis
Authors: Thalita Molinos Campos
Carolina Antunes do Prado Tavares Silva
Ana Paula Taboada Sobral
Sergio Sousa Sobral
Maria Fernanda Setúbal Destro Rodrigues
Sandra Kalil Bussadori
Kristianne Porta Santos Fernandes
Raquel Angnelli Mesquita-Ferrari
Anna Carolina Ratto Tempestini Horliana
Lara Jansiski Motta
Publication date: 01-12-2020
Publisher: Springer Berlin Heidelberg
Keyword: Laser
Published in: Supportive Care in Cancer / Issue 12/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-020-05613-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2020

Attachment style and body image as mediators between marital adjustment and sexual satisfaction in women with cervical cancer

The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review

Nutritional management of patients with oesophageal cancer throughout the treatment trajectory: benchmarking against best practice

The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia

Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry

Letter referencing “Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting in glioma patients receiving adjuvant temozolomide”

Keynote webinar | Spotlight on antibody–drug conjugates in cancer